Cardiopathy: Clinical Trials

1 trial for Cardiopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Cardiopathy: new trials by email Literature Review of Cardiopathy trials Research Report on Cardiopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19
Viusid and Asbrip - Covid-19, Sars-CoV2
Phase 2CompletedCatalysis SL602020-05-042021-01-08

Narrower conditions

COVID-19 (1)  ·  Diabetes Mellitus (1)  ·  Heart Diseases (1)  ·  Kidney Diseases (1)  ·  Liver Diseases (1)  ·  Lung Diseases (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Digestive System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glucose Metabolism Disorders (1)  ·  Infections (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nidovirales Infections (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)

Interventions

Viusid (1)

Sponsors

Catalysis SL (1)

Countries

Ecuador (1)